HOME > COMMENTARY
COMMENTARY
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (II) -2-
January 30, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (II) -1-
January 30, 2006
-
From "Replacement" to "Addition": Prescription Form
January 23, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (I) -2-
January 23, 2006
-
Vascular Calcification: Ultimate Consequnce of Vascular Atherosclerosis (I) -1-
January 23, 2006
-
A Happy Year 2006 to Japanese Pharmaceutical Stocks!
January 23, 2006
-
Industry Should Insist on Brand Average Market Price Principle
January 16, 2006
-
The Bottom of the Tornado
January 16, 2006
-
<New Year's commentary>Looking at the Pharma Industry Backward from 2009 -1- Sugio Seko, President Pharma Marketing Survey Research Laboratory (December, 2005)
January 9, 2006
-
<New Year's commentary>Looking at the Pharma Industry Backward from 2009 -2- Sugio Seko, President Pharma Marketing Survey Research Laboratory (December, 2005)
January 9, 2006
-
Schrodinger's Cat
December 12, 2005
-
Top Wholesalers Cut Costs to Offset Declines in Gross Profits
December 5, 2005
-
Importance of Framing
November 21, 2005
-
A Cluster of Diseases - Metabolic Syndrome: Reflecting Aging Society
November 7, 2005
-
A Cluster of Diseases - Metabolic Syndrome:Reflecting an Aging Society -1-
October 31, 2005
-
Commentary 2005 Will Be "Year 1" of Japanese Drug Industry Reorganization
October 17, 2005
-
COMMENTARY 2 articles
October 10, 2005
-
COMMENTARY 6 articles
September 19, 2005
-
Where Will the Japanese Pharmaceutical Industry Drift? - From "The Sky Is the Limit" to the Abyss -
August 29, 2005
-
COMMENTARY 5 articles
August 8, 2005
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
